Adherex
Latest News
bullet ADHEREX REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS
bullet Adherex Announces First Closing of Private Placement


2009 ASCO Poster: ADH-1 PDF 200 KB
WRAL.com: Video on ADH-1 and ILI Melphalan in Melanoma See the Video
Adherex Technologies Inc.
  • A team of experts dedicated to identifying, developing and commercializing novel cancer therapeutics
  • A diversified portfolio of innovative cancer peptide compounds in preclinical and clinical development
  • Three products in advanced development, each representing a major therapeutic and commercial opportunity

Adherex is focused on developing solutions to unmet needs in cancer and cognitive enhancement